Transplant Decisions in Patients with Myelofibrosis: Should Mutations be the Judge?

• Current disease risk classifications are prognostic for post-transplant outcome.• Somatic mutations affect prognosis and should be included in the decision-making process regarding transplantation
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research